for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
  PharmAsia News
  [0 followers]  Follow
   Full-text available via subscription Subscription journal
   ISSN (Print) 1875-7774
   Published by Informa plc Homepage  [15 journals]
  • Cipla Chief: Don’t Dilute India’s Patent Laws
    • Abstract: Cipla's chairman and anti-monopoly champion, Yusuf Hamied, has re-emphasized concerns around any potential dilution of India's patent regulations, given the possible ripple effects across the developing world.
      PubDate: Sun, 30 Aug 2015 04:00:01 -040
  • Asia On The Move: CFDA Deputy Head Takes On Key Liaison Role
    • Abstract: Wu Zhen is the latest China FDA senior official to serve as a liaison between the agency and the National Health and Family Planning Commission, as the regulatory reform enters a cross-agency collaboration stage.
      PubDate: Sun, 30 Aug 2015 03:40:01 -040
  • Korea Toujeo OK Sets Stage for Tresiba Clash
    • Abstract: Sanofi's next-generation basal insulin Toujeo has been approved in South Korean and looks set to compete with Novo Nordisk's Tresiba, which is also expected to be launched there soon.
      PubDate: Sun, 30 Aug 2015 03:25:01 -040
  • Wuxi PharmaTech Pushing Ahead with $3bn Go-Private Deal
    • Abstract: The continuous development of Wuxi PharmaTech needs ongoing financial support, and while US listing has been an important source for funding, the major Chinese provider of contract development services to the global pharma industry is now looking to go private in a move that aims to take advantage of favorable investor sentiment and bring value to shareholders.
      PubDate: Fri, 28 Aug 2015 04:50:00 -040
  • Indian IT Pioneer Murthy Launches Online Health Venture
    • Abstract: A well-known IT entrepreneur in India has launched the country's first healthcare exchange to link patients with doctors, clinics, hospitals, pharmacies, diagnostic labs, insurers and home care, citing a "huge online opportunity".
      PubDate: Fri, 28 Aug 2015 04:20:01 -040
  • Oscotec Plans US Trial For SYK Inhibitor Amid Failures By Others
    • Abstract: South Korean drug developer Oscotec is planning to conduct early stage clinical trials in the US for its spleen tyrosine kinase inhibitor to treat rheumatoid arthritis. The company is betting that it will be able to license out the drug candidate, which is set to become a first-in-class therapy amid development failures by global competitors.
      PubDate: Fri, 28 Aug 2015 04:05:02 -040
  • China Generic Sildenafil Market Growing But Challenges Ahead
    • Abstract: The first Chinese generic version of Viagra has racked up healthy sales since its launch and more domestic pharmaceutical companies are now readying themselves to capture the opportunity in the erectile dysfunction market with cheaper homegrown generics since Pfizer lost its Chinese patent for sildenafil last year.
      PubDate: Thu, 27 Aug 2015 05:10:01 -040
  • Govt Policies Blamed As Turkish University Hospitals Rack Up Debts
    • Abstract: University hospitals in Turkey have amassed a combined debt of TRY2.7bn ($974.7m) over recent years, with some of the leading facilities now facing the risk of bankruptcy. The situation has led to claims that the government’s reimbursement and pricing policies are exacerbating the situation, and that the ultimate aim is to weaken and then nationalize the hospitals.
      PubDate: Thu, 27 Aug 2015 04:40:01 -040
  • Korean, Foreign Pharms Call For ‘Reasonable’ Drug Price System
    • Abstract: South Korean and foreign pharma firms have jointly urged the Korean government to postpone a planned drug price cut by one year in an effort to overcome the impact of the MERS outbreak, and have promised to cooperate to propose a balanced new drug pricing system as well as to recommend steps to promote better R&D in the sector.
      PubDate: Thu, 27 Aug 2015 04:25:02 -040
  • CFDA Said Considering Shortening Oncology Drug INDs To 60 Days
    • Abstract: In one reform after another, the China FDA is acting swiftly to accelerate new drug approvals, this time with a focus on innovative cancer therapies. The agency is said to be planning a pilot scheme that would change the current investigational new drug (IND) process from an approval to a filing mechanism, and set 60 days as the timeframe.
      PubDate: Wed, 26 Aug 2015 04:35:01 -040
  • Indian Court Reserves Order In Controversial Rotavirus Vaccine Case
    • Abstract: An Indian court has reserved judgement in a case on alleged safety signals concerning an indigenously developed oral rotavirus vaccine developed through a unique local public-private partnership.
      PubDate: Wed, 26 Aug 2015 04:15:02 -040
  • Green Cross Cell Unveils Positive Progress In HCC Immunotherapy
    • Abstract: During the latest meeting of the Asian Cellular Therapy Organization, South Korea's Green Cross Cell revealed Phase III results for its Immuncell-LC immunotherapy for early stage liver cancer, which the company said resulted in reduced recurrence cut mortality rates.
      PubDate: Tue, 25 Aug 2015 03:30:01 -040
  • China Progresses Sequencing Tech Under Precision Medicine Strategy
    • Abstract: While DNA sequencing technologies have been around for a while, it is the concept of precision medicine that presents the prospect of a profitable future, and a driving force for many Chinese companies to invest in the area.
      PubDate: Tue, 25 Aug 2015 03:05:01 -040
  • Restructuring To Speed Registrations In Turkey'
    • Abstract: The Turkish Drug and Medical Device Institution has recently restructured its Drug Registration Department and taken steps to make the approval process more efficient, with the aim of using information technologies more efficiently to communicate with applicants. Although the changes have been met positively by the industry, analysts are reserving judgment until they see tangible indications the process is accelerating after the restructuring.
      PubDate: Tue, 25 Aug 2015 02:50:01 -040
  • Cipla, GSK Battle It Out In Indian Respiratory Space
    • Abstract: Competition in the fast-growing Indian respiratory market looks set to intensify with key players and traditional rivals, Cipla and GlaxoSmithKline, each outlining distinct new initiatives in the segment, where pricing is a key consideration.
      PubDate: Mon, 24 Aug 2015 04:20:01 -040
  • CFDA Unveils Milestone Plans To Accelerate New Drug Approvals
    • Abstract: A long-awaited China FDA regulatory reform plan covers a range of key areas of focus: narrowing the definition of new drugs, starting marketing authorization holder pilot schemes and widening qualifications for fast-track products. But analysts still see room to improve.
      PubDate: Mon, 24 Aug 2015 04:05:01 -040
  • Iran’s Korea Medical R&D Investment Delayed By Sanctions
    • Abstract: Amid the still uncertain timing of major countries' lifting of economic sanctions against Iran, construction of a planned Iranian traditional medical research institute in South Korea's Osong Biovalley has been postponed to the first half of next year from this year. In April, an Iranian consortium signed an agreement to invest $2bn in the biocluster to build medical facilities and develop new drugs.
      PubDate: Mon, 24 Aug 2015 03:35:02 -040
  • Turkey Regulatory Update: Cancer Drug Supplies, Partnership Regulation
    • Abstract: Implementation of a new policy for patients to buy cancer drugs from the hospital administering care has been postponed for private and university hospitals. Meanwhile, a new regulation aims to support technology transfer and to develop local industrial capacity in healthcare, and five drugs have been added to the reimbursement list.
      PubDate: Fri, 21 Aug 2015 03:55:00 -040
  • WuXi and TruTag’s Smart Tags To Help Fight Counterfeits
    • Abstract: Joint testing of an edible on-dose authentication technology by WuXi PharmaTech and TruTag Technologies is showing promising results for potential use in combatting counterfeit drugs.
      PubDate: Fri, 21 Aug 2015 02:50:01 -040
  • Korea Seeks New Law To Support Orphan Drugs, Ease Supply Disruptions
    • Abstract: Amid continued disruptions in medicine supplies and growing need to develop orphan drugs, South Korea’s government plans to submit a bill to parliament that will enable it to designate "innovative medicines" for the treatment of fatal or incurable diseases, help speed up the development and approval of innovative drugs, as well as ease supply disruptions.
      PubDate: Thu, 20 Aug 2015 11:00:02 -040
  • AZ, Merck, Sanofi The Winners In Drastic China Slowdown
    • Abstract: A drastic slowdown in China has impacted pharma multinationals, with average growth dipping by double digits in the last quarter. PharmAsia News has combed through earnings reports to bring you the winners, laggards and the most successful strategies.
      PubDate: Thu, 20 Aug 2015 05:10:02 -040
  • Australian Pharma Warns Against Removing Orphan Fee Incentives
    • Abstract: Australia's pharmaceutical industry association, Medicines Australia, has objected to proposals by the Therapeutic Goods Administration to eliminate fee waivers for the registration and evaluation of orphan drugs. The association warns that if this incentive is removed, "local sponsors may not invest in bringing these products to market in Australia as this would not be commercially viable in many instances".
      PubDate: Thu, 20 Aug 2015 04:30:00 -040
  • GSK/Desano Tie-Up Bring Large Dolutegravir Price Cuts
    • Abstract: HIV drug Tivicay is expected to become 30% cheaper in China under a recent manufacturing deal between ViiV and Desano. The Chinese firm expects to gain a 35% share of the global generic antiretroviral API supply market this year after patent licensing agreements with the Medicines Patent Pool.
      PubDate: Thu, 20 Aug 2015 04:05:01 -040
  • Korea’s Ilyang Pharm, LegoChem Boosted By Anti-Cancer Therapy Deals
    • Abstract: South Korean pharmas advance in the oncology space as Ilyang Pharm lets Colombia's Biopas sell its novel leukemia therapy Supect in 10 Latin American countries, while LegoChem Biosciences links with Fosun Pharma for development and commercialization of its antibody-drug conjugate as an anticancer therapy for the Greater China region.
      PubDate: Wed, 19 Aug 2015 09:30:01 -040
  • Does South Korea Need A State-Owned Pharma To Stabilize Supply'
    • Abstract: South Korea repeatedly faced drug supply disruptions when dealing with the outbreak of bird flu and new influenza, and when pharma firms refused to produce inexpensive but essential medicines, or drugs for rare diseases, due to low profitability. A local research paper now says the country may need a state-run pharma to ensure stable future supplies of essential medicines.
      PubDate: Tue, 18 Aug 2015 16:40:01 -040
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015